AU2002246151A1 - Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases - Google Patents

Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases

Info

Publication number
AU2002246151A1
AU2002246151A1 AU2002246151A AU2002246151A AU2002246151A1 AU 2002246151 A1 AU2002246151 A1 AU 2002246151A1 AU 2002246151 A AU2002246151 A AU 2002246151A AU 2002246151 A AU2002246151 A AU 2002246151A AU 2002246151 A1 AU2002246151 A1 AU 2002246151A1
Authority
AU
Australia
Prior art keywords
azolylcarbynol
heteroaryl
aryl
derivatives
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002246151A
Other versions
AU2002246151B2 (en
AU2002246151C1 (en
Inventor
Blas Andaluz-Matero
Jordi Frigola-Constansa
Ramon Merce-Vidal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200100817A external-priority patent/ES2174756B2/en
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Application granted granted Critical
Publication of AU2002246151C1 publication Critical patent/AU2002246151C1/en
Publication of AU2002246151A1 publication Critical patent/AU2002246151A1/en
Publication of AU2002246151B2 publication Critical patent/AU2002246151B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002246151A 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases Ceased AU2002246151B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200100817A ES2174756B2 (en) 2001-04-06 2001-04-06 DERIVATIVES OF ARIL (OR HETEROARIL) AZOLILCARBINOLES FOR THE TREATMENT OF RESPIRATORY DISEASES.
ESP200100817 2001-04-06
PCT/ES2002/000136 WO2002080908A1 (en) 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases

Publications (3)

Publication Number Publication Date
AU2002246151C1 AU2002246151C1 (en) 2002-10-21
AU2002246151A1 true AU2002246151A1 (en) 2003-04-10
AU2002246151B2 AU2002246151B2 (en) 2007-05-31

Family

ID=8497368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002246151A Ceased AU2002246151B2 (en) 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases

Country Status (22)

Country Link
US (1) US20040142994A1 (en)
EP (1) EP1384476B1 (en)
JP (1) JP2004531511A (en)
KR (1) KR20040025913A (en)
CN (1) CN1230165C (en)
AT (1) ATE289812T1 (en)
AU (1) AU2002246151B2 (en)
BR (1) BR0208807A (en)
CA (1) CA2443015A1 (en)
DE (1) DE60203106T2 (en)
DK (1) DK1384476T3 (en)
ES (2) ES2174756B2 (en)
HU (1) HUP0400925A3 (en)
IL (1) IL158268A0 (en)
MX (1) MXPA03009125A (en)
NO (1) NO20034471L (en)
NZ (1) NZ529303A (en)
PL (1) PL365251A1 (en)
PT (1) PT1384476E (en)
RU (1) RU2294198C2 (en)
WO (1) WO2002080908A1 (en)
ZA (1) ZA200308630B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335566A1 (en) * 2003-07-31 2005-02-24 Grünenthal GmbH Medicaments containing derivatives of aryl (or heteroaryl) azolylcarbinols
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
ES2244326B1 (en) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. COMBINATION OF ACTIVE SUBSTANCES.
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1820502A1 (en) * 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
WO2010123999A2 (en) * 2009-04-21 2010-10-28 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (en) * 1998-04-15 2001-07-01 Esteve Labor Dr TIENILAZOLILALCOXIETANAMINAS, ITS PREPARATION AND ITS APPLICATION AS MEDICINES.
ES2137136B1 (en) * 1998-05-18 2000-07-01 Esteve Labor Dr EMPLOYMENT OF ARYL (OR HETEROARIL) AZOLYL CARBINOL DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NEUROGENIC INFLAMMATION.
ES2150378B1 (en) * 1998-08-07 2001-07-01 Esteve Labor Dr EMPLOYMENT OF ARIL (OR HETEROARIL) AZOLILCARBINOLES DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISORDERS MEDIATED BY AN EXCESS OF SUBSTANCE P.

Similar Documents

Publication Publication Date Title
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
EP1511730B8 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
LT3143995T (en) Rapamycin derivative for the treatment of lung cancer
AU2002364300A1 (en) Polymer derivatives for the treatment of metals
AU2002362774A1 (en) Cyclosporin analogs for the treatment of lung diseases
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
AU2001285747A1 (en) Method for the treatment of tobacco
AU2002330095A1 (en) Flavonoids for treatment of diabetes
PL369062A1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
AU2002303145A1 (en) Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2002246151A1 (en) Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AU2002322263A1 (en) Eglin c based drugs for treatment of disease
HUP0400925A3 (en) Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
GB0100092D0 (en) Treatment of degenerative diseases
AU2354301A (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides for the treatment of diseases
AU2002365654A1 (en) Treatment of diseases via the skin
AU2002359282A1 (en) Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
AU2002317183B2 (en) ARYL (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence